1. Academic Validation
  2. RBT1, a novel transcriptional co-activator, binds the second subunit of replication protein A

RBT1, a novel transcriptional co-activator, binds the second subunit of replication protein A

  • Nucleic Acids Res. 2000 Sep 15;28(18):3478-85. doi: 10.1093/nar/28.18.3478.
J M Cho 1 D J Song J Bergeron N Benlimame M S Wold M A Alaoui-Jamali
Affiliations

Affiliation

  • 1 Departments of Medicine, Oncology and Pharmacology, Lady Davis Institute for Medical Research of the Jewish General Hospital, McGill University, Montreal, QC H3T 1E2, Canada.
Abstract

Replication Protein A (RPA) is required for DNA recombination, repair and replication in all eukaryotes. RPA participation in these pathways is mediated by single-stranded DNA binding and protein interactions. We herein identify a novel protein, Replication Protein Binding Trans-Activator (RBT1), in a yeast two-hybrid assay employing the second subunit of human RPA (RPA32) as bait. RBT1-RPA32 binding was confirmed by glutathione S:-transferase pull-down and co-immunoprecipitation. Fluorescence microscopy indicates that green fluorescence protein-tagged RBT1 is localized to the nucleus in vivo. RBT1 mRNA expression, determined by semi-quantitative RT-PCR, is significantly higher in Cancer cell lines MCF-7, ZR-75, SaOS-2 and H661, compared to the cell lines normal non-immortalized human mammary epithelial cells and normal non-immortalized human bronchial epithelial cells. Further, yeast and mammalian one-hybrid analysis shows that RBT1 is a strong transcriptional co-activator. Interestingly, mammalian transactivation data is indicative of significant variance between cell lines; the GAL4-RBT1 fusion protein has significantly higher transcriptional activity in human Cancer cells compared to human normal primary non-immortalized epithelial cells. We propose that RBT1 is a novel transcriptional co-activator that interacts with RPA, and has significantly higher activity in transformed cells.

Figures